Navigation Links


Thanlosartan in Medical Technology

New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes

MILAN, Italy, June 15 /CNW/ - Today AMADEO, one of the first studies to compare the protective potential of two angiotensin receptor blockers in hypertensive patients with diabetic nephropathy, was presented at the European Society of Hypertension, Milan. The results from this study show that ...
Other TagsArtArtArtArtArtArtArtArtIBMupondependdependdependtubetubetubetubetubetubetubeformulationOther Contentshearthearthearthearthearthearthearthearthearthearthelicaseturnturnturnturnturnturnturnturnturnhemoglobinhemoglobinhemoglobinhemoglobinhemoglobinhemoglobinhemoglobinhepatocytesherbivoresherbivoresheredityheredityheredityheredityheredity